Rubi sells KPTI 25.17: Karyopharm Updates Data For Selinexor In Solid Tumors At 2014 ASCO Annual Meeting
NATICK, Mass., June 2, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced multiple presentations of clinical data from an ongoing Phase 1 trial of its lead drug candidate ... ...
36 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home